Fleischmann R, et al. A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib to Placebo and to Adalimumab, in Patients with Active Rheumatoid Arthritis with Inadequate Response to Methotrexate. ACR 2018, abstract 890.
ACR 2018
okt 2018
nov 2022 | Psoriasis
nov 2020
okt 2020
aug 2020 | RA, SLE